Cancer Trials / Trials in Wyoming
35 Recruiting Trials

Clinical Trials
for Cancer in Wyoming

35 clinical trials for Cancer are currently recruiting participants at study sites in Wyoming. Study-related care is provided at no cost.

35
Recruiting trials
9
Study sites
6
Cities
8
Phase 2
22
Phase 3

Cancer clinical trials in Wyoming: what to expect

Cancer is the single largest area of clinical research, and nearly every recruiting cancer trial is written for one cancer type at one stage. Most test a new drug or combination against the current standard treatment: targeted medicines matched to a mutation found in the tumor, immunotherapies that help the immune system recognize cancer cells, antibody-drug conjugates and cell therapies. Others study surgery and radiation techniques, ways to reduce side effects, and screening or prevention in people at higher risk.

In Wyoming, recruiting cancer studies are concentrated in Cheyenne, Cody, Sheridan and Rock Springs, with sites in 2 other cities.

Who cancer trials usually look for

Every listing names the cancer type and stage it enrolls, and most also state how many earlier treatments you may have had: some are for people newly diagnosed, many are for cancer that has come back or spread after a first treatment stopped working. Targeted-therapy trials require a specific result on tumor testing, which the site can arrange if it has not been done. Trials generally ask that you are well enough for daily activity (a "performance status" the doctor scores), that blood counts and liver and kidney function are adequate, and that a few weeks have passed since your last treatment.

Having advanced or metastatic cancer does not rule you out. A large share of recruiting trials are designed specifically for it.

What taking part involves

Screening reviews your pathology and scans, often with new blood work and sometimes a fresh biopsy. Treatment then follows a cycle, typically every two or three weeks, with scans every six to twelve weeks to measure the response. Early-phase trials have more frequent visits at the start. The study drug and study-specific tests are provided at no cost; standard care that you would receive anyway is usually billed to insurance as normal. A placebo on its own is rare in cancer trials: when there is one, it is added to the standard treatment, and the consent form says so.

Questions worth asking the study team

Whether the trial is randomized and what the comparison treatment is; what happens if the cancer grows during the study; whether you can keep receiving the drug afterward if it is working; how the trial fits with the plan your own oncologist has suggested; and what travel or lodging support is offered. Your oncologist can also refer you directly.

Showing 20 of 35 recruiting Cancer trials in Wyoming

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
PHASE3 Phoenix, Arizona +4 sites NCT06876714
This trial is looking for adults with HER2-positive breast cancer who have no residual invasive disease after chemotherapy. Participants will receive either 6 or 12 months of HER2-targeted medications to see which duration works best.
Recruiting
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3 Birmingham, Alabama +4 sites NCT05879926
This trial is looking for premenopausal women with early-stage breast cancer that is hormone receptor-positive. Participants will receive hormone therapy and may also get chemotherapy to see if it helps them live longer without cancer returning.
Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
PHASE3 Phoenix, Arizona +4 sites NCT06748222
This trial is looking for younger women who have survived breast cancer and are experiencing depression. Participants will try two different mindfulness programs, one led by an instructor via Zoom and the other through a mobile app.
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
PHASE3 Anchorage, Alaska +4 sites NCT06592924
This trial is looking for men with prostate cancer that has spread and is responding poorly to current treatment. Participants will receive additional medication to see if it helps lower cancer growth and spread.
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2 Birmingham, Alabama +4 sites NCT03851445
This trial is looking for patients with previously treated non-small cell lung cancer. Participants will undergo testing and may receive new therapies that target cancer growth compared to standard treatments.
Recruiting
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
PHASE3 Anchorage, Alaska +4 sites NCT07018869
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PHASE3 Birmingham, Alabama +4 sites NCT05929768
This trial is looking for women with early-stage triple negative breast cancer. Participants will receive a shorter treatment plan involving chemotherapy and immunotherapy without a certain type of drug called anthracyclines.
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NA Anchorage, Alaska +4 sites NCT03723928
This trial is looking for women with hormone receptor positive, HER2 negative metastatic breast cancer. Participants will be monitored using specific blood tests and imaging to check how well their cancer treatment is working.
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites NCT04181060
This trial is looking for patients with advanced lung cancer that has a specific gene mutation. Participants may receive a combination of treatments or just one treatment to see which is more effective.
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 sites NCT04267848
This trial is looking for adults who have had surgery for certain stages of non-small cell lung cancer. Participants will receive a type of drug called pembrolizumab along with their usual chemotherapy treatment to help improve their chances of survival.
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
PHASE3 Birmingham, Alabama +4 sites NCT07061977
This trial is looking for individuals with advanced cervical cancer who have not received prior treatment. Participants will receive a combination of chemotherapy and an immunotherapy drug to see if it helps improve their condition.
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
PHASE3 Birmingham, Alabama +4 sites NCT07000084
This trial is looking for adults who have recurrent non-muscle invasive bladder cancer that returned after previous treatment. Participants will receive a standard treatment combined with a chemotherapy drug to see if it helps more than the standard alone.
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
PHASE3 Anchorage, Alaska +4 sites NCT07200830
This trial is looking for men with advanced prostate cancer that has not responded to hormone treatment. Participants will receive an experimental treatment schedule for a medication that targets cancer cells and may help improve their quality of life.
Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3 Anchorage, Alaska +4 sites NCT04423211
This trial is looking for men whose prostate cancer has returned after surgery. Participants will receive a combination of treatments to see if they help more than standard care alone.
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
PHASE3 Fort Smith, Arkansas +4 sites NCT07097142
This trial is looking for adults with muscle invasive bladder cancer. Participants will receive different amounts of radiation therapy while also getting standard chemotherapy treatment.
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
PHASE3 Birmingham, Alabama +4 sites NCT06580314
This trial is looking for patients with certain types of stage III or IV ovarian cancer. Participants will take a medication called olaparib for either one or two years to see how well it works alone or with another drug called bevacizumab.
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
PHASE3 Anchorage, Alaska +4 sites NCT06998940
This trial is looking for patients with advanced pancreatic cancer that cannot be surgically removed or has spread to other areas. Participants will receive standard chemotherapy and may also receive an additional drug called panitumumab to see if it can help improve treatment outcomes.
Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
PHASE3 Fayetteville, Arkansas +4 sites NCT06470243
This trial is looking for men with advanced prostate cancer that is still growing despite low testosterone levels. Participants will be treated with two chemotherapy drugs, carboplatin and cabazitaxel, to see if they work better together than cabazitaxel alone.
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3 Anchorage, Alaska +4 sites NCT03418961
This trial is looking for patients with breast cancer that has spread to other parts of the body. Participants must be receiving trastuzumab-based treatment and will be monitored for potential heart problems.
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites NCT03866382
This trial is looking for adults with rare genitourinary cancers that have spread to other parts of the body. Participants will receive a combination of treatments to see if it works better than single therapies.
Recruiting
See all 35 Cancer trials in Wyoming

Where the Cancer studies are in Wyoming

Research sites running the most studies
  • Billings Clinic-Cody, Cody25 trials
  • Memorial Hospital of Laramie County, Cheyenne20 trials
  • Welch Cancer Center, Sheridan17 trials
  • Cheyenne Regional Medical Center-West, Cheyenne6 trials
  • Memorial Hospital of Sweetwater County, Rock Springs2 trials
  • Big Horn Basin Cancer Center, Cody1 trial
By city

Counts are recruiting studies listing at least one site in Wyoming, from ClinicalTrials.gov, refreshed every two days.

Cancer clinical trials in Wyoming: common questions

How many Cancer clinical trials are recruiting in Wyoming?
TrialFinder currently lists 35 recruiting Cancer clinical trials with study sites in Wyoming. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Cancer clinical trials located in Wyoming?
Sites for these Cancer trials are spread across Wyoming. Open any trial to see its full list of participating locations and contact details.
Do I need insurance to join a Cancer clinical trial in Wyoming?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Cancer trials in Wyoming also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Cancer clinical trial in Wyoming?
Each study sets its own criteria based on age, Cancer diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of cancer treatment?
Almost never. Cancer trials compare a new treatment with the current standard treatment, or add the study drug to standard treatment. When a placebo is used it is on top of standard care, and the consent form states this before you decide.
Can I join a cancer trial if my cancer has spread?
Yes. Many recruiting cancer trials are written for advanced or metastatic disease, including people whose earlier treatments have stopped working. The listing states the stage and prior treatments it accepts.
Do I have to stop my current cancer treatment to join a trial?
It depends on the trial. Some enroll people whose current treatment has stopped working, some add the study drug to the treatment you are on, and some are for people who have not started treatment yet. Ask the study team before changing anything.
Cancer Trials in Other States
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Cancer trials near you in Wyoming.

Get Matched — Free
No insurance required
About Cancer Trials

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

All Cancer trials →
Other Conditions in Wyoming
Diabetes Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
All trials in Wyoming →